Norcolut (Norethisterone)

Norethisterone is a synthetic progestogen that binds to progesterone receptors in the hypothalamus, pituitary gland and uterine tissue. This binding suppresses the mid‑cycle luteinising hormone surge, preventing ovulation, and induces secretory changes in the endometrium that reduce bleeding and stabilize the menstrual cycle.

The dose of Norcolut is individualized by the prescribing healthcare professional based on the specific indication, patient age, weight, medical history and any concomitant medications. Only a qualified prescriber should decide the appropriate regimen, and patients should follow the written prescription without alteration.

Norcolut is generally not recommended for use during pregnancy because it is intended to prevent conception. If pregnancy occurs, the medication should be discontinued and the clinician consulted. Limited data exist for breastfeeding; therefore, a healthcare provider should evaluate the risk‑benefit balance before use in nursing mothers.

To order Norcolut, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After submission, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details and any necessary import documentation.

Norcolut delivers a progestogen‑only approach, whereas combined oral contraceptives contain both estrogen and progestogen. This can be advantageous for women who cannot tolerate estrogen, have estrogen‑sensitive conditions, or require a simpler regimen. However, progestogen‑only products may have a slightly higher failure rate if missed doses occur, so adherence is essential.

Norcolut tablets should be stored at ambient temperature, below 25 °C (77 °F). Keep the product in its original blister pack or container, protect it from moisture and direct sunlight, and keep it out of reach of children. Do not refrigerate or freeze the tablets.

Norcolut is taken orally, usually once daily at the same time each day, as directed by the prescribing clinician. The tablets are swallowed whole with water and can be taken with or without food. Patients should follow the exact schedule provided in their prescription to maintain efficacy.

The most serious risks include venous thromboembolism (deep‑vein thrombosis or pulmonary embolism), hepatic adenoma or other liver tumors, severe allergic reactions such as anaphylaxis, and worsening of depression or other psychiatric disorders. Patients should seek immediate medical attention if they experience symptoms such as unexplained leg swelling, severe abdominal pain, rash, or mood changes.

Norcolut should be avoided in women with a known hypersensitivity to norethisterone or any excipients, those with active or a history of thromboembolic disease, uncontrolled hypertension, severe liver disease, or known estrogen‑dependent tumors. It is also contraindicated during pregnancy and should be used with caution in patients with depression, migraine with aura, or smoking over 15 cigarettes per day.